Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Results (4)

    Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis-Based Medicinal Products: A k-Means Clustering Analysis of the UK Medical Cannabis Registry

    Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis-Based Medicinal Products: A k-Means Clustering Analysis of the UK Medical Cannabis Registry

    J Clin Pharmacol. 2026 Oct;66(10):e70313. doi: 10.1002/jcph.70313.ABSTRACTCannabis-based medicinal products (CBMPs) are increasingly prescribed for chronic pain, yet the supporting evidence remains limited and the extent to which patients differ in their response is poorly understood. This study applied longitudinal k-means clustering to pain-severity trajectories in patients treated with CBMPs fo
    October 16, 2026
    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Curr Pharm Des. 2026 Oct 5. doi: 10.2174/0113816128510427260927100857. Online ahead of print.ABSTRACTBACKGROUND: The global opioid crisis has intensified interest in non-opioid and opioid-sparing analgesic strategies, including cannabinoids. Despite the expanding legal landscape for cannabis and a rapidly growing cannabinoid market, the clinical evidence for cannabinoid use in acute pain managemen
    October 13, 2026
    Cannabinoids for pain management in rheumatoid arthritis: a scoping review of clinical evidence and mechanisms

    Cannabinoids for pain management in rheumatoid arthritis: a scoping review of clinical evidence and mechanisms

    Rheumatol Int. 2026 Oct 5;46(10):275. doi: 10.1007/s00296-026-06314-x.ABSTRACTPersistent pain remains a major unmet need in rheumatoid arthritis (RA), even in patients with adequately controlled inflammatory disease. Cannabinoids have been proposed as potential modulators of pain and inflammation, but their clinical role in RA remains uncertain. To map and critically appraise the available clinica
    October 5, 2026
    Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial

    Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial

    Mov Disord. 2026 Aug 7. doi: 10.1002/mds.70449. Online ahead of print.ABSTRACTBACKGROUND: There is a lack of treatments for non-motor symptoms (NMS) in Parkinson's disease (PD).OBJECTIVE: To assess the safety and effectiveness of an oral Cannabis sativa L. extract on pain and other NMS of PD.METHODS: This phase II, randomized, placebo-controlled trial evaluated a formulation containing cannabidiol
    August 7, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management